UNDA 270 (Seroyal USA)


Welcome to the PulseAid listing for the UNDA 270 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Calendula officinalis, Dulcamara, Equisetum arvense, Hypericum perforatum
SUBSTANCE NAME: SOLANUM DULCAMARA STEM; CALENDULA OFFICINALIS FLOWERING TOP; EQUISETUM ARVENSE BRANCH; HYPERICUM PERFORATUM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2017-10-17
END MARKETING DATE: 0000-00-00


UNDA 270 HUMAN OTC DRUG Details:

Item DescriptionUNDA 270 from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 4; 4; 4; 4([hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL)
START MARKETING DATE: 2017-10-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-1166_5bb0acb9-be38-7096-e053-2a91aa0adf1c
PRODUCT NDC: 62106-1166
APPLICATION NUMBER:

Other SOLANUM DULCAMARA STEM; CALENDULA OFFICINALIS FLOWERING TOP; EQUISETUM ARVENSE BRANCH; HYPERICUM PERFORATUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USAUNDA 270